Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

HCE-T cell-based permeability model: A well- maintained or a highly variable barrier phenotype? (CROSBI ID 244991)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Juretić, Marina ; Jurišić Dukovski, Bisera ; Krtalić, Iva ; Reichl, Stephan ; Cetina-Čižmek, Biserka ; Filipović-Grčić, Jelena ; Lovrić, Jasmina ; Pepić, Ivan HCE-T cell-based permeability model: A well- maintained or a highly variable barrier phenotype? // European journal of pharmaceutical sciences, 104 (2017), 23-30. doi: 10.1016/j.ejps.2017.03.018

Podaci o odgovornosti

Juretić, Marina ; Jurišić Dukovski, Bisera ; Krtalić, Iva ; Reichl, Stephan ; Cetina-Čižmek, Biserka ; Filipović-Grčić, Jelena ; Lovrić, Jasmina ; Pepić, Ivan

engleski

HCE-T cell-based permeability model: A well- maintained or a highly variable barrier phenotype?

The most extensively characterized human- derived cell line used in transcorneal permeability studies, in terms of passive transcellular and paracellular transport, transporter expression and metabolic enzymes, is the immortalized human corneal epithelial cell line (HCE-T). The purpose of this study is to describe the changes in the HCE-T barrier phenotype in vitro when valid cultivation conditions, in accordance with the standardized HCE-T cell-based model protocol, were employed. Evaluation of the structural and functional barrier properties revealed two different HCE-T barrier phenotypes, depending on the polycarbonate membrane pore size. Model I (pore size 0.4 μm) was characterized by a multilayered HCE-T epithelium at the apical side and a weak barrier function (70–115 Ω × cm2), whereas Model II (pore size 3 μm) consisted of an apical lipophilic HCE-T monolayer and a basolateral lipophilic monolayer of migrated HCE-T cells that showed improved barrier properties (1700–2600 Ω × cm2) compared with Model I. Considering the permeation of ophthalmic compounds and in vitro/ex vivo correlation, Model II was better able to predict transcorneal drug permeation. This study highlights the important aspects of HCE-T barrier phenotype variability that should be continuously monitored in the routine application of HCE-T cell-based models across both academic and pharmaceutical industry research laboratories.

Cornea ; Barrier properties ; Drug permeability ; In vitro/ex vivo correlation ; Ocular delivery

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

104

2017.

23-30

objavljeno

0928-0987

1879-0720

10.1016/j.ejps.2017.03.018

Povezanost rada

Farmacija

Poveznice
Indeksiranost